1Muss HB. Adjuvant therapy for older breast cancer patients [J].Breast, 2003,12(6) :550-557.
2Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients [ J ]. Cancer, 2004,101 (6) :1302-1310.
3Bobo JK, Lawson HW, Lee NC, et al. Risk factors for failure to detect a cancer during clinical breast examinations ( United States ) [ J ]. Cancer Causes Control, 2003, 14 ( 5 ): 461-468.
7Christopher A, Garces MD, William G, et al. Neoadjuvant chemotherapy of breast cancer [ J ]. Am Surg, 2004,70 (7) :565-569.
8De Michele A, Putt M, Zhang Y, et al. Older age predicts a decline in adjuvant chemotherapy recommendation for patients with breast carcinoma evidence from a tertiary care cohort of chemotherapy-eligible patients [J]. Cancer, 2003, 97 (9): 2150-2159.
10Singh R, Hellman S, Heimann R. The natural history of breast carcinoma in the elderly: implication for screening and treatment [ J ]. Cancer, 2004,100(9) :1807-1813.
3Muss HB.Adjuvant therapy for older women with breast cancer.Breast,2003,12:550-557.
4Yancik R.Cancer burden in the aged:an epidemiologic and demographic overview.Cancer,1997,80:1273-1283.
5DeMichele A,Putt M,Zhang Y,et al.Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma:evidence from a tertiary care cohort of chemotherapyeligible patients.Cancer,2003,97:2150-2159.
6Wyld L,Garg DK,Kumar ID,et al.Stage and treatment variation with age in postmenopansal women with breast cancer:compliance with guidelines.Br J Cancer,2004,90:1486-1491.
7Bobo JK,Lawson HW,Lee NC.Risk factors for failure to detect a cancer during clinical breast examinations (United States).Cancer Causes Control,2003,14:461-468.
8Subramaniam DS,Isaacs C.Utilizing prognostic and predictive factors in breast cancer.Curr Treat Options Oncol,2005,6:147-159.
9Jonsson H,Tornberg S,Nystrom L,et al.Service screening with mammography of women aged 70-74 years in Sweden.Cancer Detect Prev,2003,27:360-369.
10Houterman S,Janssen-Heijnen ML,Verheij CD,et al.Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients.Br J Cancer,2004,90:2332-2337.
6Gigerenzer G,Mata J,Frank R.Public knowledge of benefits of breast and prostate cancer screening in Europe[J].J Natl Cancer Inst,2009,101(17):1216-1220.
7Gao CM,Tajima K,Ding JH,et al.Body size,physical activity and risk of breast cancer-a case control study in Jiangsu Province of China[J].Asian Pac J Cancer Prev,2009,10(5):877-881.
8Zhu C,Luo J,Shi H,et al.Expression of tubulin,p53,ki67,receptors for estrogen,and progesterone in endometrial cancer[J].Eur J Gynaecol Oncol,2009,30(5):514-517.
9Zellweger T,Gunther S,Zlobec I,et al.Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer[J].Int J Cancer,2009,124(9):2116-2123.
10Penault-Llorca F,Andre F,Sagan C,et al.Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer[J].J Clin Oncol,2009,27(17):2809-2815.
